TSC1 and Burkitt lymphoma: Focusing on redox stress, Götz Hartleben found that mTORC1-inhibitor tuberous sclerosis 1 (TSC1) ensures homeostasis between oncogenic factors MYC and mTORC1 through the repression of both mitochondrial oxygen consumption and mitochondrial reactive oxygen species (mtROS) production In Burkitt's lymphoma cells.